Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhancing a diverse population: the American Thoracic Society Mentoring Program for Underrepresented in Medicine.

ATS scholar·2026

Same author

[Characteristics of peak expiratory flow and analysis of risk factors for its decline in stroke patients].

Zhonghua yi xue za zhi·2026

Same author

Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Adverse events associated with sequential immune checkpoint inhibitor and alectinib in patients with ALK-rearranged advanced non-small-cell lung cancer.

ESMO open·2025

Same author

[Study on the effect and burden of precipitation on road traffic injuries in Zhejiang Province].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

Same author

[Identification of endothelial cell key genes associated with pathogenesis and invasion of human venous malformations using single-nucleus RNA sequencing-based co-expression network analysis].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

The TRAINE Program for Networking T32 Cancer Prevention Fellows Across Institutions: a Preliminary Report.

J P Wisnivesky¹, M McVeety², B F Fuemmeler³

¹Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, 17 East 102 Street, New York, NY, 10029, USA. juan.wisnivesky@mountsinai.org.

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education

|May 31, 2026

Summary

The Trainee Research Acceleration through Information and Networking Exchange (TRAINE) program enhanced cancer research training by connecting trainees across institutions. This program successfully expanded professional networks and improved scientific communication for early-career investigators.

More Related Videos

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Published on: October 9, 2015

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Published on: October 9, 2015

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

Area of Science:

Cancer Prevention and Control Research
Health Services Research
Medical Education

Background:

National Institutes of Health T32 programs offer foundational cancer research training but have limited cross-institutional networking and mentorship opportunities.
A well-connected research workforce is crucial for advancing cancer research.
Gaps in professional development exist for early-career cancer researchers.

Purpose of the Study:

To introduce the Trainee Research Acceleration through Information and Networking Exchange (TRAINE) program, a multi-institutional collaboration.
To describe TRAINE's objectives: expanding professional networks, fostering research collaborations, and improving scientific communication.
To evaluate the initial two years of the TRAINE program's impact on cancer prevention and control trainees.

Main Methods:

TRAINE facilitated structured virtual and in-person exchange visits between predoctoral and postdoctoral trainees and faculty at partner institutions.
The program focused on networking, collaboration, and scientific communication practice through research presentations.
Nineteen Cancer Prevention and Control fellows participated in the program over its first two years.

Main Results:

Post-visit surveys revealed high trainee satisfaction with the program.
Trainees valued external faculty feedback, peer networking, job talk practice, and exposure to diverse research environments.
All participants recommended the TRAINE program to their peers, indicating its perceived value.

Conclusions:

The TRAINE program offers a practical and scalable model for enhancing professional development in cancer research.
It provides a novel approach to strengthening the pipeline of early-career investigators in cancer prevention and control.
TRAINE successfully addressed limitations in existing training programs by fostering inter-institutional connections and skill development.